| Description | ZK-261557 is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under investigation for the treatment of solid tumors. |
| molecular weight | 378.81 |
| Molecular formula | C20H15ClN4O2 |
| CAS | 300843-21-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |